Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives.

Bioorg Med Chem Lett

Department of Chemistry, Boehringer Ingelheim (Canada) Ltd, Research & Development, 2100 Cunard Street, Laval, Québec, Canada H7S 2G5.

Published: February 2004

A series of 8-heteroarylthiomethyldipyridodiazepinone derivatives were prepared and evaluated for their antiviral profile against wild type virus and the important K103N/Y181C mutant as an indicator for broad activity. 2,6-Dimethylpyridine derivative 16 was found to have a good pharmacokinetic profile in spite of poor metabolic stability in rat liver microsomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2003.11.049DOI Listing

Publication Analysis

Top Keywords

8-heteroarylthiomethyldipyridodiazepinone derivatives
8
novel nevirapine-like
4
nevirapine-like inhibitors
4
inhibitors improved
4
improved activity
4
activity nnrti-resistant
4
nnrti-resistant hiv
4
hiv 8-heteroarylthiomethyldipyridodiazepinone
4
derivatives series
4
series 8-heteroarylthiomethyldipyridodiazepinone
4

Similar Publications

Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives.

Bioorg Med Chem Lett

February 2004

Department of Chemistry, Boehringer Ingelheim (Canada) Ltd, Research & Development, 2100 Cunard Street, Laval, Québec, Canada H7S 2G5.

A series of 8-heteroarylthiomethyldipyridodiazepinone derivatives were prepared and evaluated for their antiviral profile against wild type virus and the important K103N/Y181C mutant as an indicator for broad activity. 2,6-Dimethylpyridine derivative 16 was found to have a good pharmacokinetic profile in spite of poor metabolic stability in rat liver microsomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!